Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
NASDAQ
19.764,89
0,98%
Bitcoin
93.986,81
-0,74%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Personalis Inc (PSNL) Personalis Inc (PSNL) Notizie

Personalis Inc

PSNL
5,95
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 12:27:37
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202415:06EDGAR2Form 8-K - Current report
19/12/202415:00BWPersonalis Advances Business Strategy with Investment from..
18/12/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202414:00BWPersonalis and Tempus Expand Collaboration to Biopharma
20/11/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:01BWPersonalis to Participate at Upcoming Investor Conferences
06/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:01BWPersonalis Reports Third Quarter 2024 Financial Results
06/11/202422:00EDGAR2Form 8-K - Current report
05/11/202422:01BWPersonalis to Present at the Stifel 2024 Healthcare..
23/10/202422:01BWPersonalis to Announce Third Quarter 2024 Financial Results
19/9/202423:28EDGAR2Form 8-K - Current report
16/9/202415:00BWESMO 2024 Data Expands on Compelling Performance of..
12/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
30/8/202422:43EDGAR2Form S-3 - Registration statement under Securities Act of..
22/8/202422:01BWPersonalis to Participate at Upcoming Investor Conferences
20/8/202422:27EDGAR2Form SC 13D/A - General Statement of Acquisition of..
20/8/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202422:05BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
16/8/202415:25EDGAR2Form 8-K - Current report
16/8/202414:30BWPersonalis and Tempus Announce Expanded Collaboration
07/8/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:01BWPersonalis Reports Second Quarter 2024 Financial Results
07/8/202422:00EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEMyriad Genetics Reports Strong Second Quarter 2024 Financial..
01/8/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:01BWPersonalis to Participate at the 9th Annual Needham Virtual..
24/7/202422:01BWPersonalis to Announce Second Quarter 2024 Financial Results
11/7/202415:00GLOBEMyriad Genetics and Personalis Cross-License Foundational..
18/6/202422:01BWPersonalis to Participate at the TD Cowen 3rd Annual Tools /..
13/6/202414:00BWPersonalis Provides Dial-in and Updated Date for ASCO..
04/6/202422:05BWASCO Data Highlights NeXT Personal® Ultra-sensitive MRD..
31/5/202415:05BWPersonalis Announces Start of Cancer MRD Testing..
22/5/202415:05BWPersonalis Announces Podium Presentations and Abstracts..
22/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:12EDGAR2Form 8-K - Current report
17/5/202422:05BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
08/5/202422:01BWPersonalis Reports First Quarter 2024 Financial Results
08/5/202422:00EDGAR2Form 8-K - Current report
24/4/202422:01BWPersonalis to Announce First Quarter 2024 Financial Results
28/3/202421:01BWPersonalis to Present at the 23rd Annual Needham Virtual..
28/3/202414:00BWData Showcasing NeXT Personal MRD Test to be Presented at..
26/3/202414:00BWPersonalis Announces Publication Validating NeXT Personal®..
19/3/202421:43BWPersonalis Announces Inducement Grants Under Nasdaq Listing..
28/2/202422:01BWPersonalis Reports Fourth Quarter and Full Year 2023..
28/2/202422:00EDGAR2Form 8-K - Current report
14/2/202422:01BWPersonalis to Announce Fourth Quarter and Full Year 2023..
Apertura: Min: Max:
Chiusura: 5,95

La tua Cronologia

NASDAQ
PSNL
Personalis
BOV
H1IG34
Hartford Financial Servi...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network